MLB: Rhys Hoskins set for ACL surgery on Opening Day

Date:

Share post:


Philadelphia Phillies first baseman Rhys Hoskins will undergo ACL surgery on his left knee Thursday — Opening Day across Major League Baseball.

The team announced that Hoskins will have the reconstruction surgery in Fort Worth, Texas. As fate would have it, the Phillies open their season about 15 miles away in Arlington against the Texas Rangers.

Hoskins, 30, is expected to miss the entire season.

Hoskins suffered the injury during a spring training game last Thursday while attempting to plant his foot making a play on a ball as he reached the outfield grass just beyond first base. He remained on the ground for several minutes while being tended to by trainers and emergency medical personnel.

Hoskins, who is set to become a free agent after this season, underwent surgery in the offseason to repair the meniscus in his right knee.

He batted .246 with 30 homers and 79 RBIs in 156 games last season for the Phillies. He also played a major role in Philadelphia’s run to the World Series by belting six homers — including four in the National League Championship Series versus the San Diego Padres.

Hoskins is a career .242 hitter with 148 homers and 405 RBIs in 667 career games with Philadelphia.

–Field Level Media

spot_img

Related articles

MLB: Jack Suwinski’s late homer lifts Pirates past Cubs

Jack Suwinski played the hero in his hometown on Friday as his ninth-inning home run lifted the visiting...

MLB: Brewers reinstate RHP Jacob Misiorowski from injured list

The Milwaukee Brewers reinstated rookie right-handed pitcher Jacob Misiorowski from the 15-day injured list on Friday in order...

MLB: Braves activate OF Ronald Acuna Jr. from injured list

The Atlanta Braves activated All-Star outfielder Ronald Acuna Jr. from the 10-day injured list on Friday. He landed on...

MLB: HR prop targets for August 15

Another Midwest heat wave puts our longball focus on a few big bats in the middle of the...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.